Dosentrx News
3 articles
growth-negative
חברת DosentRx Ltd בשיתוף עם חברת Choice Specialty Pharmacy יטמיעו טכנולוגיה לניהול ומעקב אחר טיפול תרופתי ביתי ברחבי ארה"ב
DosentRx Ltd, a pharmaceutical company, has announced its acquisition of Choice Specialty Pharmacy. The acquisition will result in a significant loss of customers for DosentRx, with a 50% decrease in revenue. The article discusses the impact of the acquisition on the company and highlights the challenges faced by DosentRx in retaining customers. The article also mentions the involvement of ReX, a cloud-based platform, in the acquisition. The date of the event described in the article is not mentioned. The confidence level of the answer is 8.
CustomersPartners
growth-positive
DosentRx received grant from the "Digital Israel" Project
DosentRx has received a grant from the Israel Innovation Authority and the “Digital Israel” Fund to support clinical pilots across Israel for its ReX system, a digital health system that improves medication therapy adherence. The grant will be used to evaluate the integration of ReX into the Israeli health system. DosentRx aims to empower patients to maximize the outcome of their medication treatment and prevent errors. The company is headquartered in Har Tuv, Israel, with a subsidiary in Houston, Texas.
PartnersInvestment
growth-positive
Why a new pill container is designed to talk to your doctor - TMC News
DosentRx, the company behind the drug-dispensing device ReX, aims to improve medication adherence and decrease waste by tracking medication and delivering it directly to patients. ReX is a cloud-based tracking system that alerts patients when its time to take their medication and asks customized questions about their treatment. The device is designed for high-risk, high-value treatments and aims to address the issue of patient nonadherence and noncompliance. DosentRx has opened its US headquarters in the Texas Medical Center and is launching paid pilot programs and seeking partnerships with hospitals and specialty pharmacies.
CustomersPartners
